Two phthalocyanine derivatives tetra-peripherally substituted
with
tert
-butylsulfonyl groups and coordinating either
zinc(II)
or platinum(II) ions have been synthesized and subsequently investigated
in terms of their optical and photochemical properties, as well as
biological activity in cellular, tissue-engineered, and animal models.
Our research has revealed that both synthesized phthalocyanines are
effective generators of reactive oxygen species (ROS).
PtSO
2
t
Bu
demonstrated
an outstanding ability to generate singlet oxygen (Φ
Δ
= 0.87–0.99), while
ZnSO
2
t
Bu
in addition to
1
O
2
(Φ
Δ
= 0.45–0.48) generated
efficiently other ROS, in particular ·OH. Considering future
biomedical applications, the affinity of the tested phthalocyanines
for biological membranes (partition coefficient; log
P
ow
) and their primary interaction with serum albumin were
also determined. To facilitate their biological administration, a
water-dispersible formulation of these phthalocyanines was developed
using Pluronic triblock copolymers to prevent self-aggregation and
improve their delivery to cancer cells and tissues. The results showed
a significant increase in cellular uptake and phototoxicity when phthalocyanines
were incorporated into the customizable polymeric micelles. Moreover,
the improved distribution in the body and photodynamic efficacy of
the encapsulated phthalocyanines were investigated in hiPSC-delivered
organoids and BALB/c mice bearing CT26 tumors. Both photosensitizers
exhibit strong antitumor activity. Notably, vascular-targeted photodynamic
therapy (V-PDT) led to complete tumor eradication in 84% of
ZnSO
2
t
Bu
and 100% of
PtSO
2
t
Bu-
treated mice, and no recurrence has so far been
observed for up to five months after treatment. In the case of PtSO
2
t
Bu, the effect was significantly stronger,
offering a wider range of light doses suitable for achieving effective
PDT.